Alnylam Pharmaceuticals
ALNY
#649
Rank
$39.15 B
Marketcap
$293.26
Share price
0.42%
Change (1 day)
8.54%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company